. 2013 Nov 23;209(8):1219–1226. doi: 10.1093/infdis/jit654

Table 2.

Sequence Variants Observed Without Prior Antiviral Therapy

Sequence Variant^a	Subjects (N)^b
G629S	4
I341T	3
(F718L)^c	3
A269V, P375L, L394F, (H446Y), A472V, K519R, A614V, Q639H, P656S	2
G201E, S212F, (R264G), A285S, (V327G), Q323H, A336T, V337M, (N345S)^d, K426R, V450G, H465Y, A473V, (V483A), P617S, P628A, V634A, Q651E, G653S, (S660N), R800C, *(G822D)^c, (M828V)^c, R847H, N855D, H863R, T892I, (E903G)^c, (G920S), V927M, S1000L, D1005N*, (R1006C)^d	1

^a Variants in parentheses were detected only as mixtures with wild type. Variants in italics are at conserved residues. Variants in bold were selected for phenotyping.

^b Number of subjects noted to have each listed mutation. At least 1 subject per mutation had no history of prior anti-cytomegalovirus therapy.

^c Not found on resequencing of any of the involved specimens.

^d Mixture confirmed on resequencing of the involved specimen.